Form 4: NeuroOne Medical Technologies Executive Reports Stock Disposal
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on August 31, 2024, to cover tax obligations.
Summary
- On August 31, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed at a price of $0.7964 per share.
- This disposal was likely to cover tax obligations related to vesting of stock or option exercise, as indicated by transaction code 'F'.
- Following the transaction, Christianson directly owns 294,512 shares of NeuroOne Medical Technologies Corp common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock transaction, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for investors to monitor.
Key Dates
| Date | Description |
|---|---|
| 08/31/2024 | Date of stock disposal transaction. |
| 09/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.